Genes
Oligo Pools
NGS
Variant Libraries
Synthetic Controls
Antibody Discovery
IVDR Solutions
Webinars
Featured Webinars
High-Throughput Production and Deep Characterization of VHH Antibodies: Unlocking Biophysical and Functional Insights for AI/ML-Driven Therapeutic Discovery
Assises de Génétique 2026 - Utilisation de l’exome Twist en diagnostic clinique
.png)
Toward a molecular system capable of self-regeneration
Advancing Cancer Research with NGS: Custom Panels, Liquid Biopsy & Methylation
.png)
From Sequences to Systems: Designing a Next-Gen Wet Lab
GenesTwist and Cradle discuss how to build an iteration-focused lab environment to rapidly validate and improve machine learning models for biologics discovery.
Hit Two Birds with One Stone: Hybrid-capture
NGSHit Two Birds with One Stone: Hybrid-capture
Various challenges in clinical genomic testing
NGS
UltraSensitive Residual Leukemia Detection with Patient-Specific Duplex Sequencing
NGSDr. Jesse Salk reviews using Duplex Sequencing to measure ultra-rare mutations from carcinogens, aging, and the earliest stages of cancer.
Multi-cancer Early Detection by means of Cell-free DNA Methylation in Solid Tumors
NGS
Academia Genómica de Twist Bioscience
NGSExperimente una uniformidad superior y un menor coste de secuenciación con los paneles personalizados de enriquecimiento de regiones de interés con Twist Bioscience.
From Womb to Wheeze: Investigating the Epigenetic Predisposition to Respiratory Disease.
NGS
Writing the Future of Infectious Disease
NGSWriting the Future of Infectious Disease
Capabilities of the New Twist NGS Methylation Detection System
NGSAn end-to-end solution for library preparation, conversion and target enrichment of genomic samples to identify regions of methylation.
Meta-Analysis of 150+ Antibody Campaigns: Transgenic Mice vs. Single B-Cell Tech Trends
Biopharma
Principles and Applications of Methylome Analysis for Cancer and Other Disease Research.
NGS
Weizmann Institute Discusses Epitranscriptome Screening
NGSDr. Schraga Schwartz speaks about epitranscriptome screening for the characterization of the pseudouridine landscape on mammalian RNA
Writing the Future of Antibody Development and Optimization
Antibodies
Raising the Bar for NGS Target Enrichment @ ESHG 2022
NGS
Unlocking precision medicine through expert NGS panel design
NGS
Custom CRISPR Screening Libraries with Desktop Genetics
Oligo PoolsWatch this webinar on CRISPR screening, presented by Twist Bioscience in partnership with Desktop Genetics, hosted by Front Line Genomics
Nature and Nurture for Improved Enzyme Activity
GenesUse diverse native sequences and directed evolution to improve enzyme activity on target reactions
Decoding Nucleic Acid Language of Cis-Regulatory Elements through High-Throughput Experiment and Deep Learning
Genes
Writing The Future Of Cancer Research
Genes
Decoding transcriptional regulation using massively parallel reporter assays and Twist Oligo Pools
Oligo PoolsThe latest advances in studying gene expression regulation
Artificial DNA synthesis technology paves the way for research into non-model organisms: Insights from studies
Genes
From Bones to Genomes: Genetic Investigation of Late Iron Age Individuals from North and South of the Alps
NGS
Unlock the Full Potential of RNA-Seq
NGS.png)
Faster Answers, Fewer Steps: Streamline Your Targeted Sequencing with Trinity Freestyle™
NGS
Writing the Future of Biologics to Discover and Optimize Antibodies
Biopharma
Next generation CRISPR screens based on single-cell transcriptomics
Oligo PoolsCombining CRISPR screening and single cell transcriptomics to enable genetic screening for complex phenotypes.
Using Twist technology to efficiently enrich 1.4 million SNP targets for ancient DNA analysis
NGS
Aplicación de Tecnologías para la Investigación de SARS-CoV-2
Synthetic ControlsNuestros productos están teniendo impacto en la evaluación, vigilancia, desarrollo de vacunas y descubrimiento de terapias inmunológicas.
Revealing Cancer Dependencies and Determinants of Therapeutic Response Using CRISPR
Oligo Pools
Explore Sequence Space With Twist Bioscience Spread Out Low Diversity Libraries
Variant Libraries
Comprehensive analysis of CRISPR/Cas3 genome editing by Twist Custom Panel
NGS
Using the Twist Pan Viral Panel to Enhance Viral Whole-genome Sequencing I AGBT 2018
NGSMike Wiley discusses his project using the Twist Pan Viral Panel to identify targets to create better diagnostics for Liberia
Writing the Future of Biologics to Discover and Optimize Antibodies
BiopharmaDr Aaron Sato presents how Twist Biopharma leverages Twist Bioscience's DNA synthesis technology to rapid end-to-end antibody discovery
Ensuring high resolution CNV detection
NGS
#WeMakeDNA - Epigenomics approach to rare disease and cancer screening
NGS
Collaborating for Cocktails: The Coronavirus Immunotherapeutics Consortium (CoVIC)
NGSCollaborating for Cocktails: The Coronavirus Immunotherapeutics Consortium (CoVIC)
A PCR-Free Hybrid Capture Approach for Detection of Pathogenic Repeat Expansions
NGS
Master IVDR Compliance Anytime, On-Demand Webinar
NGSLearn expert strategies for IVDR compliance with Twist Bioscience. Watch at your own pace today!
Identification of Dickkopf-1 (DKK1) Antibodies Utilizing a Multi-Faceted Discovery
Biopharma
Rapid and efficient production of FISH probes using oligo pools with Nicola Crosetto
Oligo PoolsTwist Bioscience synthetic Oligo Pools can be combined with the iFISH platform to quickly and cost-effectively produce oligo FISH probes
Comprehensive identification of multiple respiratory viruses including SARS-CoV-2 in a single assay
NGSThe COVID-19 pandemic has highlighted the urgent need for genomic tools that can accurately and fully characterize samples
#WeMakeDNA - Synthetic Biology and Microbiology for Understanding Evolutionary Mechanisms
Genes
Writing The Future Of Cancer Research - Panel Discussion Part 1
Genes
Leading the way in Sample Prep- Corporate workshop presentation at AMP 2020
NGS
ESHG 2025: Unleash the Power of Your Samples: Next-Level Sequencing with Twist Bioscience
NGS
The Next Generation of Targeted Methylation Sequencing
NGSThe Next Generation of Targeted Methylation Sequencing
Unveiling the Dynamics of SARS-CoV-2 Variant Evolution and its implications
Biopharma
Low-coverage Whole-genome Sequencing Improves Precision and Speed of Genomics-assisted Crop Improvement
NGSJosh Clevenger
The utility of exome sequencing analysis
NGSDr. Júlia Baptista discusses the utility of exome sequencing analysis in solving rare genetic disorders: the Exeter experience
Unraveling the Dual Role of HNF1A Variants: From Rare Diabetes Forms to Atherogenic Lipoproteins
Variant Libraries
Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens
GenesUsing Twist’s clonal genes and gene fragments, Resurrect Bio scaled the screening of thousands of AI-designed genes—building an efficient funnel for trait discovery, from in silico prediction to in planta validation.
Using Novel Tools of Synthetic Biology to Understand Complex Diseases via Functional Genomics
Oligo PoolsUsing Novel Tools of Synthetic Biology to Understand Complex Diseases via Functional Genomics
From Poultry to Peanuts: Low-Coverage WGS to uncover important traits in Chickens and Production Plants
NGS
Validating a diagnostic cfDNA NGS assay
NGS
Precision with a Purpose: Benchmark 659 for Cancer Care - Powered by Twist Bioscience
NGS
Genome Modeling and Design: From the Molecular to Genome Scale
GenesBrian Hie at Stanford discusses training Evo2, a genomic foundation model, with 9.3 trillion nucleotides from over 128,000 genomes.
Reading and Writing the Future of Antibodies
Biopharma
Gene to Chemicals: An Adventure of Molecular Engineering Across Scales
GenesFong Tian Wong at A*STAR IMCB explores how synthetic biology and molecular engineering can activate silent biosynthetic gene clusters in actinobacteria, streamlining metabolite production and enabling the discovery of novel compounds.
SARS-CoV-2 Variants: How to "Capture" them
NGSSARS-CoV-2 Variants: How to "Capture" them
A Cost-Effective Pan-Genome-Based Platform for Genotype Imputation, QTL Mapping, and Breeding Support
NGS
Innovations in Genetic Screening: The Power of CRISPRgate for Transcriptome Engineering
Oligo PoolsUnlock the full potential of your genetic screens with CRISPRgate’s innovative dual-action approach to boost editing efficiency, consistency, and impact.
Writing the Future of Biologics (PEGS Boston 2022)
BiopharmaAaron Sato, CSO
Using Plant Synthetic Biology for Sustainable, High-yield Rubber Production
Genes
Building Better AI With High-Resolution Functional Genomics Data
Oligo PoolsCi Chu at Xaira explores new approaches to generating large-scale, single-cell perturbation datasets that overcome key challenges in throughput, variability and batch effects.
The role of clinical exome sequencing in the genome world
NGS
Rewriting Cancer's Script: Insights from Saturation Genome Editing
Genes
Developing an Integrated MRD Assay to Transform Oncology
NGS
Advanced Targeted Sequencing: Unraveling the Complexity of Plant Genetic Diversity
NGS
Accelerating Recombinase Reprogramming with Machine Learning
GenesFelix Lansing at SeamlessTx explores how data-driven approach accelerates the generation of high-performance recombinases, thereby expanding the therapeutic potential of gene editing.
Scalable and combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted seq
Oligo Pools
Ancient DNA panel improves protocol for degraded samples: the Altwies mother-child burial
NGS
Unlocking precision medicine through expert NGS panel design_
NGS
Cellular reprogramming for the scalable production of human cells
GenesAdvances in cellular reprogramming have opened new doors for studying human cells in health and disease, drug discovery, and the development of cell therapies
Writing the Future With Twist Bioscience
GenesWriting the Future With Twist Bioscience
Using amino acid composition and conservation for more efficient CRISPR screens
Oligo PoolsA new, best-in-class scoring algorithm for efficacious sgRNA library production
Next Generation Synthetic Antibody Libraries Paired with Kinetic Assays for High Throughput Screens
BiopharmaDr. Aaron Sato discusses Twist Biopharma's next generation high throughput antibody discovery platform
Writing the Future of Biologics using the Twist Biopharma Library of Libraries
Biopharma
Séminaire NGS & Virologie : Innovations et applications I French Virology Application Seminar
NGS
Leading the Way in Target Enrichment: Targeted Methylation Sequencing
NGS
Comprehensive CRISPR-Cas9 screen identifies important factors for plasmablast development
Biopharma
Writing the Future of Human Genetics
NGS
Powering AI-Based Protein Engineering With Scalable Data
Oligo PoolsDiscover how A-Alpha Bio explores large-scale measurement of protein-protein interactions is building the data foundation for next-generation discovery.
On Demand Webinar: Population-Based Genomic Newborn Screening: Results of BabyDetect Study
NGS
Decoding transcriptional regulation using massively parallel reporter assays and Twist Oligo Pools
Biopharma
'Yeastern' Medicine: Brewing nightshade drugs with genetically modified yeast using whole-cell engineering
NGS
Large-scale screening of lipid-binding proteins by CLiB assay and its application in machine learning
Oligo Pools
Writing the Future of Drug of Discovery and Development
BiopharmaWriting the Future of Drug of Discovery and Development
Writing the Future of Biologics with Synthetic DNA and Machine Learning
Biopharma
Using AI to design proteins that inhibit bacterial heme-piracy
Genes
Bespoke Functional Genomics for AI
Oligo Pools
Metagenomics in lung tumor tissue using shotgun sequencing with high nucleotide diversity
NGS
UPenn uses Twist Custom Panels for canine cancer detection
NGSFind out how custom panels for target enrichment have been developed for precision veterinary oncology.
Writing the Future of Cell Therapies
Biopharma
From Exome Capture to Data Analysis: Integrating Workflow for Maximum Insight
NGSDr. Emmanuel Martin explains the productive partnership with Twist Bioscience and the use of the Twist Human Core Exome Kit.
Microfluidic Nano-Scale qPCR for Ultra-Sensitive and Quantitative Detection of SARS-CoV-2
NGSMicrofluidic Nano-Scale qPCR for Ultra-Sensitive and Quantitative Detection of SARS-CoV-2
Weill Cornell uses Twist Panels for Sequencing Age-Related Mutation Patterns
NGSDr. Duane Hassane discusses clonal hematopoiesis (CH) and preleukemia using Twist technology
Raising the Bar in NGS with Twist Bioscience
NGS
Long-Read Capture with Twist Target Enrichment
NGS
Optimizing Target Enrichment for Complex Genomes: A Case Study in Southeastern Blueberries
NGS
Cell-Free DNA methylation analysis for cancer detection
NGS
Low coverage whole genome sequencing improves precision and speed of genomics-assisted crop improvement
NGSLow cost per sample with Twist’s HT 96-Plex Library Prep kit
Targeted DNA-Seq und Whole-Exome-Seq zirkulierender zellfreier DNA zur Lymphom-Diagnostik
NGS
Clinical metagenomics for improved surveillance and diagnosis of infections in New South Wales, Australia
NGS
Mapping All Viruses on Earth and a Few for Mars
NGSMapping All Viruses on Earth and a Few for Mars
Addressing the challenges of high-throughput SARS-CoV-2 testing
NGS
Launching an NGS Assay for Estimating Genetic Ancestry and Providing Health Insights
NGSDiscover How Ancestry recently made the shift to Twist Custom Panels
Using Next Generation CRISPR Screens To Advance Our Understanding of T Cell Biology
Oligo Pools
Lab-in-the-Loop: Smarter AI for Antibody Design
GenesVladimir Gligorijevic at Genentech explores how combining AI-driven design with targeted lab testing accelerates the discovery of high-performance therapeutic antibodies, reducing experimental burden and improving candidate quality.
#WeMakeDNA - Synthetic Biology for the Study of Infectious Diseases
NGSAnnual Meeting of Molecular Biology Society of Japan 2020
Writing The Future Of Cancer Research - Panel Discussion Part 2
NGS
Mega-scale experimental analysis of protein folding stability in biology and design
Oligo Pools
Improving Cell Therapies with High-throughput CAR Libraries
Biopharma
Targeted capture through Twist cfDNA LP Kit enables sensitive detection of mutations from cell-free DNA
NGS
Broader framework for high-efficiency target enrichment, by Ramsey Zeitoun
NGSDr. Ramsey Zeitoun discusses how Twist’s suite of NGS Solutions maximize sequencing efficiency by enabling coverage and uniformity
Emily Leproust presents at ASHG 2020
NGS
Accurate CRC Detection by Targeted MethylSeq of ctDNA
NGS
Twist Biopharma Solutionsと描く抗体探索とエンジニアリングの未来像
Biopharma
Prediction of prime editing insertion efficiencies using sequence features and DNA repair determinants
Oligo Pools
Advanced characterization of antibodies by leveraging DiversimAb
Antibodies
“Full Steam Ahead!” – taking synthetic biology to the high throughput era
GenesSynthetic Biology continues to move forward at speed, enabled by the iterative cycle of ‘Design-Build-Test-Learn’ (DBTL) for DNA and strain engineering.
Comprehensive Omics Analysis to Explore Applications in Clinical Oncology
NGSComprehensive Omics Analysis to Explore Applications in Clinical Oncology
Broad Institute implements Twist Custom Exomes for cfDNA | AGBT 2019
NGSBrendan Blumenstiel, Broad Institute of MIT and Harvard, describes the development of a target enrichment workflow for cell free DNA
Capabilities of the Twist NGS Methylation Detection System
NGS
Evolution of Exome Targeted Re-sequencing Analysis: A Comparative Study of Various Methods (Japanese)
NGS
Clinical rapid whole exome sequencing with a Twist
NGSHow Radboud University Medical Center integrate exome sequencing to study disease
Capturing the Resistome: a Culture-free Approach Based on ARESdb
NGSCapturing the Resistome: a Culture-free Approach Based on ARESdb
Sequencing 100,000s of Humans: Lessons, Challenges, Hopes
NGSSequencing 100,000s of Humans: Lessons, Challenges, Hopes
Genomic Surveillance of Emerging Viruses in Massachusetts and West Africa
NGSGenomic Surveillance of Emerging Viruses in Massachusetts and West Africa
Twist Antibody Optimization Platform: Creating higher affinity antibody variants
BiopharmaDr. Tom Yuan presents a poster discussing the TAO Platform used to optimize a low-affinity antibody through its custom algorithm
De Novo Design of G Protein Mimetics
GenesDe Novo Design of G Protein Mimetics
Changing paradigm on Therapeutics targeting Membrane Proteins: from antigen production to candidate validation
NGS
Demystifying End-to-End DNA Sequencing Solutions
NGS
AZ700: Exploratory NGS Panel for Use in Translational Oncology
NGSAZ700: Exploratory NGS Panel for Use in Translational Oncology
Prioritization of Antimicrobial Targets by CRISPR-based Oligo Recombineering
Oligo PoolsPrioritization of Antimicrobial Targets by CRISPR-based Oligo Recombineering
Precision Synthesis of Variant Libraries Enables Comprehensive Interrogation of Single-Site
Variant LibrariesBiopharma
HudsonAlpha Institute uses Twist Custom Panels for Deep Exome Sequencing of FFPE Samples | AGBT 2018
NGSDr. Shawn Levy discusses the superior performance of Twist probes for high capture efficiency using diverse samples
Helix upgrades to Twist Custom Exomes for broader genetic insights | AGBT 2019
NGSDr. William Lee discusses design and optimization of an enhanced medical exome using Twist technology
DNA methylation signatures for cardiovascular and metabolic disease
NGS
No More Arrays: Genotyping by Sequencing Enables Economical and Improved Association Studies
NGS
Enzyme identification and engineering for novel industrial enzymes
Genes
Characterization of Transgene Status in Genome Edited Plant Lines Using Target Capture Sequencing Technology
NGSSathya Jali | Pairwise Plants
Accelerated Antibody Discovery Targeting the SARS_CoV-2 Spike Protein for COVID-19 Therapeutic Potential
Variant Libraries
ANTI-IDIOTYPIC MAB DISCOVERY PART I: SCREENING STRATEGY FOR ANTI-IDIOTYPIC MAB (ANTI-ID) AS CRITICAL PK/ADA AS
Biopharma
Pairing Pet Dogs With New Genomics Technologies Accelerates Cancer Diagnostic Development
NGSElinor Karlsson & Kate Megquier
HT-SPR Technology to Inform and Accelerate the Antibody Discovery Process
BiopharmaHT-SPR Technology to Inform and Accelerate the Antibody Discovery Process
Targeting Tumor Mutations with Personalized T Cell Therapy of Cancer
Genes
Genome-wide Screen of SARS-CoV-2 Identifies Hyper-potent siRNAs for Nasal Administration
Oligo PoolsYaniv Erlich | Eleven Therapeutics
Discovering PARP inhibitor resistance mechanisms using genome-wide and focused CRISPR screens
Oligo PoolsDr. Stephen Pettitt explores the limits of genome-wide targeted mutagenesis screens and the genetic basis of gene resistance
Increasing the throughput of NGS sequencing through rational design and empirical validation of 10,
NGS
AET 2024: Leveraging cutting-edge DNA Technologies to build precision libraries for Antibody Engineering
Biopharma
Implementation of Twist Products in Clinical Genomics
NGS
Getting a grip: The molecular mechanisms of Bdellovibrio attachment
Genes
感染症ウイルス検出の新時代 A New Era of Detection of Viruses Causing Infectious Diseases
NGS
Synthetic Biology for the Study of Analyzing Protein Structure and Function
Genes
Twist Corporate Satellite Symposium - ESHG 2024
NGSDream it, sequence it: New Sequencing technologies to enable your brightest discoveries
Research of Epigenetics and Epigenetic Age in Iwate Tohoku Medical Megabank Organization
NGS
Translation of Fundamental Biological Research Towards New Medicines
BiopharmaSteve Jackson
Sequencing The Future Together @ ESHG 2023
NGS
Targeted Tools for SARS CoV 2 Research with Mark Consugar and Venkatesh Moktali
NGSNGS
Evolution of Clinical Genomics: How technology drives change in diagnostic practise
NGS
Transformación de exoma clínico dirigido a secuenciación completa del exoma, de manera rentable
NGSAumento en la calidad de secuenciado utilizando el Kit de Exoma Twist’s Human Core sin afectar los costos.
Designing Enzymes for the Infinite Recycling and Upcycling of Plastic
Genes
Culture-independent sequencing in Australian public health microbiology
NGS
Synthetic DNA Technologies Enable Fast and Responsive anti-GPCR Antibody Discovery and Optimization
Biopharma
Discover Antibody Candidates Against a Panel of Hard-to-Drug GPCR Targets
BiopharmaA Synthetic Antibody Library Case Study
Travelling Back in Time with Synthetic Biology: New Insights into Fundamental Biophysical Processes
GenesTravelling Back in Time with Synthetic Biology: New Insights into Fundamental Biophysical Processes
AGBT 2019: Data-Driven Development of a High-Throughput Target Enrichment System
NGSRamsey Zeitoun of Twist's R&D team revealed new data on the latest target enrichment technologies in the Twist Portfolio at AGBT 2019
Antibody Discovery and Development Efforts Fueling the Future of Diagnostic Testing
BiopharmaLearn how Twist Biopharma has used its proprietary platform to produce and discover highly specific antibodies which may be used for developing diagnostic tests
Built With Biology Podcast: Why Should Everyone Care About Biosecurity?
Genes
Identifying and Cloning Neoepitope Specific T-Cells from Newly Diagnosed Glioma Patients
Genes
Harnessing the diversity of CRISPR-Cas proteins for genome editing
Genes
Finding new causes of hereditary breast cancer: Resolving the role of inherited promoter hypermethylation
NGS
Tips for studying metalloproteins overproduced from the corresponding synthetic genes in Escherichia coli
Genes
Towards new-generation diagnostic schemes utilizing targeted RNASeq and robotics-based DNA Methylation Seq
NGS
Screening Synthesised Effector Gene Libraries to Rapidly Identify Immune-Recognised Virulence Genes in Plant
Genes
Garantizando la identificación de CNV de alta resolución
NGSDescubra cómo la plataforma SOPHiA y el kit Twist Human Core Exome proporcionan una solución fiable y eficaz para la detección de CNV
CRISPR-Cas9 Screening in Human Pluripotent Stem Cells
Oligo PoolsDr. Ihry of Novartis Neuroscience describes CRISPR-Cas9 Screening in Human Pluripotent Stem Cells for Target Discovery
Blueprint Genetics evaluates Twist Custom Panels for hereditary disease | AGBT 2019
NGSDr. Pertteli Salmenperä of Blueprint Genetics details the importance of coverage uniformity in NGS testing of hereditary disorders
Saving Lives by Detecting Cancer Early
NGSSaving Lives by Detecting Cancer Early | Ken Chahine | Helio Health
Demystifying End-to-End DNA Sequencing Solutions
NGS
Synthetic DNA Technologies Enable the Discovery of G Protein-Coupled Receptor Antibody Ligands
Biopharma
Antiverse: Engineering the Future of Drug Discovery
Variant Libraries
Ginkgo Bioworks, Biology by Design: Applying Gigabases of DNA to Bioengineering
GenesAccess to high volumes of synthetic DNA has transformed the design-build-test-learn cycle at Ginkgo Bioworks
Development of a Universal Pan-pathogen Infectious Disease Diagnostic
NGSDevelopment of a Universal Pan-pathogen Infectious Disease Diagnostic
Twist Exome 2.0 Webinar
NGSThoughtfully Curated Content Paired with Best-in-class Performance
iGEM 2023 - The Future Is (Already) Being Written in DNA
Oligo PoolsInspiring the Next 20 Years of Discovery in Synthetic Biology
Panel-based sequencing strategies for infectious diseases
NGS
A Custom Hybrid Capture-based NGS Assay to Detect Circulating Tumor DNA
NGSMaartje Geerlings | Radboud
In Silico Accelerated Antibody Characterization
Variant LibrariesMabSilico Astrid Musnier
Exploration of bottlenecks in the protein secretory pathway in yeast
Genes
TwinStrand Biosciences discusses Duplex Sequencing
NGSDr. Jesse Salk reviews using Duplex Sequencing to measure ultra-rare mutations from carcinogens, aging, and the earliest stages of cancer.
Shedding Light on Dark Genes
NGSEnhanced targeted resequencing by optimizing the combination of enrichment technology and DNA fragment length
Enabling Clinical Trials and Translational Studies with Twist
NGSShubha Anand | University of Cambridge
Targeted Sequencing-based Genotyping as a Competitive Alternative to Genotyping Arrays
NGS
TWIST custom and cost-effective NGS panels - MedGenome Experience
NGS
Artificial Intelligence in Drug Discovery & Development
NGS
Targeted Epigenome Sequencing of cfDNA to Improve Sensitivity for Early Cancer Detection
NGSDiscover how the Cancer Research UK early detection program engaged with the Twist Targeted Methylation Sequencing Alpha Program to enable the analysis of cancer markers in cell-free DNA
CHOP uses Twist Custom Panels on challenging samples | AGBT 2019
NGSDr. Renata Pellegrino discusses how to improve sequencing on challenging samples using Twist technology
Developing Therapeutics Against Virtually Any Target with New Antibody Libraries (Mandarin)
Biopharma
Exoma completo, una estrategia eficiente para el estudio de leucemias familiares
NGS
OneShot: Advancing Forensic Biology with Integrated Genetic and Epigenetic Sequencing
NGS
Screening, diagnosis, prediction - Genomic data for the whole of life
NGS
Improving Targeted Methylation Sequencing
NGS
Biology by Design: Using High-throughput DNA Synthesis to Drive Biological Discovery
GenesBiology by Design: Using High-throughput DNA Synthesis to Drive Biological Discovery
Improved mutation detection with targeted sequencing
NGSDetecting known and novel mutations in a host's SARS-CoV-2 population by ultra-deep sequencing with unique molecular barcodes
Stronger, tighter, and faster: designing new protein functions
Genes
Predicting prognosis using circulating tumor DNA in uveal melanoma
NGS
Developing custom monoclonal antibody panels for the study of bat immunity
Antibodies
Sensitive Methylation Sequencing of ctDNA for early Cancer Detection
NGS
Development and Application of Methods for Targeted Long-Read Methylation Analysis from Small Amount of DNA
NGS(Presented in Japanese Language)
Twist Targeted Panels in Clinical Genetic Diagnostics
NGS
Partnering for IVDR Compliance: On-Demand Webinar
NGSDiscover collaborative insights from Twist Bioscience and Platomics on IVDR compliance. Watch this expert-led webinar on-demand today!
Foundation Medicine NGS Video: Christine Malbeouf I AGBT 2018
NGSDr. Christine Malbeouf compares capture methods for FFPE RNA-sequencing using Twist technology
Synthetic DNA Technologies Enable Fast and Responsive SARS-CoV-2 Antibody Discovery and Optimization
BiopharmaSynthetic DNA Technologies Enable Fast and Responsive SARS-CoV-2 Antibody Discovery and Optimization
Discovery of Synthetic Lethal Paralog Pairs in the Human Genome
Oligo PoolsDiscovery of Synthetic Lethal Paralog Pairs in the Human Genome
Twist Bioscience: High Throughput Antibody Expression Service
Antibodies
Genomic profiling including DNA methylation analysis for challenging cancers of unknown primary
NGS
Precision Variant Library Technology Allows for Focused Screening
Variant LibrariesCombinatorial Variant Libraries Poster
Emily Leproust, PhD | Introduction to Twist Bioscience | AGBT 2019
NGSDr. Emily Leproust discusses how Twist Bioscience is leading the way in target enrichment
Developing stable heterogeneous enzymes for fine chemical production
GenesThe advantages of gene synthesis for rapid, low-cost enzyme optimization and delivery
Transforming Natural Product Drug Discovery Through DNA Synthesis
GenesTransforming Natural Product Drug Discovery Through DNA Synthesis
DNA methylation biomarker discovery for complex diseases using Twist Human Methylome
NGS
Harnessing the Power of Surveillance Testing on Small Residential College Campuses
NGSHarnessing the Power of Surveillance Testing on Small Residential College Campuses
Developing Blood Biopsy Technology Using a New Canine Exome Capture
NGS
Increasing the Precision of Precision Medicine for Children with High-risk Cancer
NGSIncreasing the Precision of Precision Medicine for Children with High-risk Cancer
BEAT 2.0 – Ichnos’ Next Generation Bi- and Multi-specific Antibody Platform
Genes
A Platform to Develop Highly Potent and Functional Antibodies Against G-Protein Coupled Receptors
BiopharmaTwist Bioscience's Gene Synthesis technology allows Twist Biopharma to rapidly identify antibodies against GPCRs
Tools for the Good Fight
BiopharmaTools for the Good Fight
Horsehair whorls
NGSRakan Naboulsi | Swedish University of Agricultural Sciences
Amyris discusses Next-Generation Platforms for Strain Optimization
GenesDr. Sunil Chandran discusses how Twist Clonal Genes are enabling Amyris with their microbial engineering efforts.
The Evolution of Clinical Genomics at VCGS: Past, Present & Future
NGSThe Evolution of Clinical Genomics at VCGS: Past, Present & Future
Tools for Addressing the COVID-19 pandemic
NGSHear from Venkatesh Mokitali from Twist Bioscience on the tools we are developing to address the SARS-CoV-2
U of Verona | Enhanced Targeted Reseq. by DNA Insert Length Optimization | Dr Delledonne | AGBT 2019
NGSDr. Delledonne of University of Verona describes how DNA fragment length impacts NGS data quality.
Connecting Plant Trait Genotypes to Phenotypes using WGS Skim-Seq
NGS
A Systematic Strategy to Link Human Genetic Variations to Drug Response
GenesA Systematic Strategy to Link Human Genetic Variations to Drug Response
Epitranscriptome Screening on TechNetworks
Oligo PoolsMassively Parallel Reporter Assays powered by Twist Oligo Pools enable Epitranscriptome Screening
Accelerate GPCR Antibody Discovery with Synthetic DNA Technologies
BiopharmaAccelerate GPCR Antibody Discovery with Synthetic DNA Technologies
Analysis of Somatic Mosaicism through Comprehensive Genomic and Epigenomic Profiling of Small Samples
NGS
Deciphering Cancer Mutations and Clinical Applications through NGS and Technological Innovations
NGS
GPCR Libraries with a twist from Dr. Aaron Sato
Biopharma
DNA methylation based liquid biopsy for multi-cancer detection.
NGS
Advancements in Epigenetic Analysis tools for Disease Research
NGS
Expanding the Toolbox for Agrigenomics
NGSPaul Doran
Predictive Profiling of SARS-CoV-2 Variants by Deep Mutational Learning
Variant LibrariesPredictive Profiling of SARS-CoV-2 Variants by Deep Mutational Learning
Drugging the undruggable with protein interference
Oligo Pools
High-throughput evaluation of genome editing tools
Oligo Pools
Custom enrichment for RNA sequencing of liquid biopsies
NGSBelieve in Better: Leading the Way in Target Enrichment
Hyperimmune scFv Library: Pure Biologics and Twist Bioscience Partnering
BiopharmaPure Biologics and Twist Bioscience Partnering
Synthetic DNA Technologies Enable Antibody Discovery and Optimization
BiopharmaWebinar on Twist's proprietary DNA writing technology and approaches for creating synthetic DNA libraries for phage display-based discovery
Antibody Discovery At The Edge Of Impossible
BiopharmaSelf Labelling Integral Membrane (SLIM) display - a novel mammalian display strategy for targeting membrane proteins at the cell surface
Toward a molecular system capable of self-regeneration
Genes
Advancing Cancer Research with NGS: Custom Panels, Liquid Biopsy & Methylation
NGS
High-Throughput Production and Deep Characterization of VHH Antibodies: Unlocking Biophysical and Functional Insights for AI/ML-Driven Therapeutic Discovery
Antibodies
This webinar explores how combining in silico and in vitro methods provides a blueprint